Skip to main content
. 1998 Sep;72(9):7501–7509. doi: 10.1128/jvi.72.9.7501-7509.1998

TABLE 3.

Neutralizing antibody responses on the day of challenge

Challenge group Neutralizing antibody responsea
Protection?
TCLA SIVmac251 Primary SIVmac251 Cloned SIVmac239
5 week
 1472 231 15 <4 No
 1474 304 9 <4 No
 1476 1,093 <4 <4 No
 1478 1,014 9 <4 No
 1480b <20 <4 <4 No
10 week
 1482 1,499 22 9 No
 1484 409 29 10 No
 1488 2,613 8 7 Yes
 1490 1,549 <4 10 Yes
 1492b <20 <4 <4 No
15 week
 1494 3,288 22 26 Yes
 1496 3,904 25 10 Yes
 1498 898 <4 <4 Yes
 1502 350 <4 <4 Yes
 1504b <20 <4 <4 No
25 week
 1506 774 9 16 Yes
 1510 3,625 <4 29 No
 1512 2,747 <4 20 Yes
 1514 9,039 74 23 Yes
 1516b <20 <4 <4 No
a

Reciprocal serum dilution to yield a 50% reduction in virus-induced cell killing in CEMx174 cells. 

b

Nonimmunized control animal.